E. Lynne Kelley
Plus aucun poste en cours
Profil
E.
Lynne Kelley is currently the Chief Executive & Medical Officer at Signalexis, Inc. Previously, she held positions as Medical Director at Kimberly-Clark Corp.
and Boston Scientific Corp., Assistant Professor at Yale University, and Vice President-Medical Affairs at Becton, Dickinson & Co. She also served as Chief Medical Officer at Histogenics Corp., Senseonics Holdings, Inc., and X4 Pharmaceuticals, Inc. Kelley received her undergraduate degree from Boston University and her doctorate from Dartmouth Medical School.
Postes actifs de E. Lynne Kelley
| Sociétés | Poste | Début |
|---|
Anciens postes connus de E. Lynne Kelley
| Sociétés | Poste | Fin |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 03/04/2020 |
| OCUGEN, INC. | Directeur Technique/Scientifique/R&D | 23/01/2019 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/01/2016 |
| KIMBERLY-CLARK CORPORATION | Directeur Technique/Scientifique/R&D | 01/12/2010 |
| BOSTON SCIENTIFIC CORPORATION | Directeur Technique/Scientifique/R&D | 01/01/2007 |
Formation de E. Lynne Kelley
| Boston University | Undergraduate Degree |
| Dartmouth Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| BECTON, DICKINSON AND COMPANY | Health Technology |
| KIMBERLY-CLARK CORPORATION | Consumer Non-Durables |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
